Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference


– Data to be presented supports development of rademikibart for patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation –

Read more:
Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference

Related Posts